This analysis identifies a novel mechanism for keratin regulation via YAP1 in palmoplantar skin disorders, highlighting potential therapeutic targets.
Palmoplantar skin is structurally and molecularly distinct from other body sites. Notably, the type 1 keratin 9 (KRT9/K9) is exclusively expressed in palmoplantar epidermis. Mutations in KRT9/K9 are causative for epidermolytic palmoplantar keratoderma (EPPK), a genetic disorder typified by palmoplantar keratoderma. Surprisingly little is known about the ontogeny, regulation and significance of Krt9/K9. Here we characterize the regulation of Krt9/K9 in postnatal palmoplantar epidermis and uncover a novel role of K9 in modulating YAP1 signaling. Expression of Krt9/K9 rises dramatically post-birth, following a transient induction of the stress-related keratin 16 (Krt16/K16). Krt9 null mice exhibit elevated K16 and aberrant nuclear-localized YAP1 by postnatal day 3. K9 interacts with 14-3-3σ to sequesters YAP1 in the cytoplasm, while EPPK-causing pathogenic variants impair these properties. Inhibition of YAP1 in vivo ameliorates palmoplantar keratoderma in Krt9 null mice. These findings provide novel insight into the adaptation of palmoplantar skin and suggest new therapeutic avenues for diseases featuring PPKs.
No takes yet. Share an insight, caveat, or question.
Steiner et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: